Hwaseong, South Korea

Joungmin Han

This inventor holds 1 USPTO granted patent. Top assignee: Daewon Pharm., Co., Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joungmin Han. Retrieved from https://idiyas.com/inventor/joungmin-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joungmin Han: Innovator in Pharmaceutical Formulations

Introduction

Joungmin Han is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral formulations. His work focuses on enhancing the bioavailability and stability of medications, which is crucial for effective treatment outcomes.

Latest Patents

One of Joungmin Han's key patents is titled "Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability." This patent discloses an innovative oral formulation of pelubiprofen that demonstrates an improved dissolution rate and stability. The advancements in this formulation allow for high bioavailability, enabling rapid pharmacological effects. Additionally, the formulation can be stored with high stability due to the minimal generation of related compounds.

Career Highlights

Joungmin Han is currently associated with Daewon Pharm., Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in formulation science has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Joungmin has collaborated with talented colleagues, including Chankyu Jeoung and Sehhyon Song. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical products.

Conclusion

Joungmin Han's contributions to pharmaceutical formulations highlight his commitment to improving medication efficacy and stability. His innovative work continues to impact the field positively, paving the way for advancements in patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…